169 related articles for article (PubMed ID: 27747682)
1. Cefoperazone/Sulbactam-Induced Abdominal Wall Hematoma and Upper Gastrointestinal Bleeding: A Case Report and Review of the Literature.
Cai Z; Yang W; He Y; Chen Q; Wang S; Luo X; Wang X
Drug Saf Case Rep; 2016 Dec; 3(1):2. PubMed ID: 27747682
[TBL] [Abstract][Full Text] [Related]
2. A Comparison of Coagulation Function in Patients Receiving Aspirin and Cefoperazone-Sulbactam With and Without Vitamin K
Wu S; Wu G; Wu H
Clin Ther; 2021 Dec; 43(12):e335-e345. PubMed ID: 34819242
[TBL] [Abstract][Full Text] [Related]
3. Effect of Cefoperazone/Sulbactam on Blood Coagulation Function in Infected Emergency Department Patients and the Necessity of Vitamin K1 (VK1) Preventive Intervention: A Single-Center, Retrospective Analysis.
Shao X; Ren Y; Xie N; Fan K; Sun H; Lu J; Wei J; Tian X
Med Sci Monit; 2023 Jun; 29():e939203. PubMed ID: 37271979
[TBL] [Abstract][Full Text] [Related]
4. Fatal Vitamin K-Dependent Coagulopathy Associated with Cefoperazone/Sulbactam: A Case Report.
Hu HR
Drug Saf Case Rep; 2019 Jun; 6(1):6. PubMed ID: 31201572
[TBL] [Abstract][Full Text] [Related]
5. Cefoperazone Induced Gastrointestinal Bleeding.
Katukuri GR; Maddala RN; Ramamoorthi K; Hande M
J Clin Diagn Res; 2016 Aug; 10(8):OD10-1. PubMed ID: 27656491
[TBL] [Abstract][Full Text] [Related]
6. Hemolytic Anemia and Reactive Thrombocytosis Associated With Cefoperazone/Sulbactam.
Zhou L; Bao J; Ma J
Front Pharmacol; 2019; 10():1342. PubMed ID: 31798450
[No Abstract] [Full Text] [Related]
7. Cefoperazone-sulbactam and risk of coagulation disorders or bleeding: a retrospective cohort study.
Wang W; Liu Y; Yu C; Tan J; Xiong W; Dong D; Li S; Zhang R; Li J; Wu Y; Zong Z; Su N; Zou K; Wu G; Sun X
Expert Opin Drug Saf; 2020 Mar; 19(3):339-347. PubMed ID: 31914329
[No Abstract] [Full Text] [Related]
8. A case report of rash induced by cefoperazone sodium and sulbactam sodium plus metronidazole sodium chloride combined with morphine hydrochloride.
Huang J; Zhu X; Jiang C; Liu Z
Ann Palliat Med; 2020 Nov; 9(6):4377-4383. PubMed ID: 33302688
[TBL] [Abstract][Full Text] [Related]
9. Risk Factors for Cefoperazone/Sulbactam-Induced Coagulation Disorder.
Miao W; Guo J; Cheng H; Zhao Q
Infect Drug Resist; 2023; 16():6277-6284. PubMed ID: 37766881
[TBL] [Abstract][Full Text] [Related]
10. Comparison of bleeding risk and hypofibrinogenemia-associated risk factors between tigecycline with cefoperazone/sulbactam therapy and other tigecycline-based combination therapies.
Zhang L; Cai X; Peng F; Tian S; Wu X; Li Y; Guo J
Front Pharmacol; 2023; 14():1182644. PubMed ID: 37351509
[No Abstract] [Full Text] [Related]
11. Laryngeal dyspnea in relation to an interaction between acenocoumarol and topical econazole lotion.
Wey PF; Petitjeans F; Lions C; Ould-Ahmed M; Escarment J
Am J Geriatr Pharmacother; 2008 Aug; 6(3):173-7. PubMed ID: 18775393
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and Influencing Factors of Coagulation Dysfunction Caused by Cefoperazone/Sulbactam.
Zeng J; Zou M; Min M; Xu M
Altern Ther Health Med; 2024 Jan; ():. PubMed ID: 38290444
[TBL] [Abstract][Full Text] [Related]
13. Cefoperazone-sulbactam combination in the treatment of urinary tract infections: efficacy, safety, and effects on coagulation.
Greenberg RN; Reilly PM; Weinandt WJ; Bollinger M; Kennedy DJ
Clin Ther; 1987; 10(1):52-6. PubMed ID: 3329965
[TBL] [Abstract][Full Text] [Related]
14. Acute localized exanthematous pustulosis caused by cefoperazone and sodium sulbactam.
Qu YJ; Jin SB; Han XC; Zheng LQ
An Bras Dermatol; 2016; 91(6):808-810. PubMed ID: 28099605
[TBL] [Abstract][Full Text] [Related]
15. Comparison of cefoperazone plus sulbactam with clindamycin plus gentamicin as treatment for intra-abdominal infections.
Greenberg RN; Cayavec P; Danko LS; Bowen K; Montazemi R; Kearney PA; Johnson SB; Strodel WE
J Antimicrob Chemother; 1994 Sep; 34(3):391-401. PubMed ID: 7829413
[TBL] [Abstract][Full Text] [Related]
16. [Laboratory and clinical study of sulbactam/cefoperazone (SBT/CPZ) on bacterial prostatitis].
Suzuki K; Horiba M
Hinyokika Kiyo; 1991 Oct; 37(10):1333-43. PubMed ID: 1755429
[TBL] [Abstract][Full Text] [Related]
17. A fatal case of suspected anaphylaxis with cefoperazone and sulbactam: LC-MS analysis.
Tsujikawa K; Kuwayama K; Miyaguchi H; Kanamori T; Iwata Y; Inoue H; Kishi T
J Forensic Sci; 2008 Jan; 53(1):226-31. PubMed ID: 18279263
[TBL] [Abstract][Full Text] [Related]
18. Cefoperazone-sulbactam for treatment of intra-abdominal infections: results from a randomized, parallel group study in India.
Chandra A; Dhar P; Dharap S; Goel A; Gupta R; Hardikar JV; Kapoor VK; Mathur AK; Modi P; Narwaria M; Ramesh MK; Ramesh H; Sastry RA; Shah S; Virk S; Sudheer OV; Sreevathsa MR; Varshney S; Kochhar P; Somasundaram S; Desai C; Schou M
Surg Infect (Larchmt); 2008 Jun; 9(3):367-76. PubMed ID: 18570578
[TBL] [Abstract][Full Text] [Related]
19. Liquid chromatography/tandem mass spectrometry assay for the simultaneous determination of cefoperazone and sulbactam in plasma and its application to a pharmacokinetic study.
Zhou Y; Zhang J; Guo B; Yu J; Shi Y; Wang M; Zhang Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Nov; 878(30):3119-24. PubMed ID: 20971044
[TBL] [Abstract][Full Text] [Related]
20. A retrospective analysis of carbapenem-resistant Acinetobacter baumannii-mediated nosocomial pneumonia and the in vitro therapeutic benefit of cefoperazone/sulbactam.
Xia J; Zhang D; Xu Y; Gong M; Zhou Y; Fang X
Int J Infect Dis; 2014 Jun; 23():90-3. PubMed ID: 24726664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
